Projects per year
Fingerprint
Dive into the research topics where Steven D. Goodman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment
Bailey, M. T. (PI), Besner, G. E. (CoPI) & Goodman, S. D. (CoPI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
09/19/24 → 05/31/25
Project: Research
-
HMGB1-mediated host response to chronic bacterial infection
Goodman, S. D. (PI)
National Institute of Allergy and Infectious Diseases
09/22/20 → 08/31/25
Project: Research
-
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis
Trebley, J. (PI), Bailey, M. T. (CoPI), Besner, G. E. (CoPI) & Goodman, S. D. (CoPI)
National Institute of General Medical Sciences
08/15/19 → 07/31/21
Project: Research
-
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis
Besner, G. E. (PI) & Goodman, S. D. (CoPI)
National Institute of General Medical Sciences
08/1/17 → 04/30/19
Project: Research
-
Tunable Native Probiotic Formulations for the Treatment of NEC.
Besner, G. E. (PI), Bailey, M. T. (CoPI) & Goodman, S. D. (CoPI)
National Institute of General Medical Sciences
04/1/17 → 03/31/21
Project: Research
-
An engineered peptide derived from the innate immune effector high-mobility group box 1 disrupts and prevents dual-genera biofilms formed by common respiratory tract pathogens
Rhodes, J. D., Kelly, T. J., Goodman, S. D. & Bakaletz, L. O., 2025, In: FEMS Microbiology Letters. 372, fnaf029.Research output: Contribution to journal › Article › peer-review
-
Corrigendum to Noninflammatory 97-amino acid High Mobility Group Box 1 derived polypeptide disrupts and prevents diverse biofilms. EBioMedicine 107 (2024) (eBioMedicine (2024) 107, (S2352396424003402), (10.1016/j.ebiom.2024.105304))
Rhodes, J. D., Devaraj, A., Robledo-Avila, F., Balu, S., Mashburn-Warren, L., Buzzo, J. R., Partida-Sanchez, S., Bakaletz, L. O. & Goodman, S. D., Feb 2025, In: EBioMedicine. 112, 105589.Research output: Contribution to journal › Comment/debate
-
Mycobacterium abscessus biofilm cleared from murine lung by monoclonal antibody against bacterial DNABII proteins
Jurcisek, J. A., Kurbatfinski, N., Wilbanks, K. Q., Rhodes, J. D., Goodman, S. D. & Bakaletz, L. O., Mar 2025, In: Journal of Cystic Fibrosis. 24, 2, p. 374-381 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Corrigendum: ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics(Front. Microbiol., (2023), 14, (1202215), 10.3389/fmicb.2023.1202215)
Kurbatfinski, N., Kramer, C. N., Goodman, S. D. & Bakaletz, L. O., 2024, In: Frontiers in Microbiology. 15, 1382491.Research output: Contribution to journal › Comment/debate
Open Access -
Extracellular DNA-protein interactions
Goodman, S. D., Dec 2024, In: Current Opinion in Structural Biology. 89, 102943.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations